Lewy body pathology exacerbates brain hypometabolism and cognitive decline in Alzheimer’s disease.
14 September, 2024
Nat Commun. 2024 Sep 14;15(1):8061. doi: 10.1038/s41467-024-52299-1. PMID: 39277604 Free PMC article.
Read the articleBlood Biomarkers to Detect Alzheimer Disease in Primary Care and Secondary Care
28 July, 2024
JAMA. 2024 Jul 28:e2413855. doi: 10.1001/jama.2024.13855. Online ahead of print.PMID: 39068545
Read the articlePlasma Phosphorylated Tau 217 and Aβ42/40 to Predict Early Brain Aβ Accumulation in People Without Cognitive Impairment
JAMA Neurol. 2024 Jul 28:e242619. doi: 10.1001/jamaneurol.2024.2619. Online ahead of print.PMID: 39068669 Free PMC article.
Read the articleMRI Signature of α-Synuclein Pathology in Asymptomatic Stages and a Memory Clinic Population
JAMA Neurol. 2024 Jul 28:e242713. doi: 10.1001/jamaneurol.2024.2713. Online ahead of print.PMID: 39068668
Read the articleRevised criteria for the diagnosis and staging of Alzheimer’s disease
28 June, 2024
Nat Med. 2024 Jun 28. doi: 10.1038/s41591-024-02988-7. Online ahead of print.PMID: 38942991 No abstract available.
Read the articleDisease progression modelling reveals heterogeneity in trajectories of Lewy-type α-synuclein pathology
15 June, 2024
Nat Commun. 2024 Jun 15;15(1):5133. doi: 10.1038/s41467-024-49402-x.PMID: 38879548 Free PMC article.
Read the articleTau Positron Emission Tomography for Predicting Dementia in Individuals With Mild Cognitive Impairment
10 June, 2024
JAMA Neurol. 2024 Jun 10:e241612. doi: 10.1001/jamaneurol.2024.1612. Online ahead of print.PMID: 38857029 Free PMC article.
Read the articleDisease staging of Alzheimer’s disease using a CSF-based biomarker model
12 May, 2024
Nat Aging. 2024 May;4(5):694-708. doi: 10.1038/s43587-024-00599-y. Epub 2024 Mar 21.PMID: 38514824 Free PMC article.
Read the articleA blood-based biomarker workflow for optimal tau-PET referral in memory clinic settings
14 March, 2024
Nat Commun. 2024 Mar 14;15(1):2311. doi: 10.1038/s41467-024-46603-2.PMID: 38486040 Free PMC article.
Read the articleHighly Accurate Blood Test for Alzheimer’s Disease Comparable or Superior to Clinical CSF Tests.
21 February, 2024
Nat Med. 2024 Feb 21. doi: 10.1038/s41591-024-02869-z. Online ahead of print.PMID: 38382645
Read the articlePlasma Biomarker Strategy for Selecting Patients With Alzheimer Disease for Antiamyloid Immunotherapies.
1 January, 2024
JAMA Neurol. 2024 Jan 1;81(1):69-78. doi: 10.1001/jamaneurol.2023.4596.PMID: 38048096
Read the articleThe α-synuclein PET tracer [18F] ACI-12589 distinguishes multiple system atrophy from other neurodegenerative diseases.
27 October, 2023
Nat Commun. 2023 Oct 27;14(1):6750. doi: 10.1038/s41467-023-42305-3.PMID: 37891183 Free PMC article.
Read the articleDOPA decarboxylase is an emerging biomarker for Parkinsonian disorders including preclinical Lewy body disease.
3 October, 2023
Nat Aging. 2023 Oct;3(10):1201-1209. doi: 10.1038/s43587-023-00478-y. Epub 2023 Sep 18.PMID: 37723208 Free PMC article.
Read the articleCognitive effects of Lewy body pathology in clinically unimpaired individuals.
14 September, 2023
Nat Med. 2023 Aug;29(8):1971-1978. doi: 10.1038/s41591-023-02450-0.
Read the articleClinical effects of Lewy body pathology in cognitively impaired individuals.
Nat Med. 2023 Aug;29(8):1964-1970. doi: 10.1038/s41591-023-02449-7.
Read the articleCSF MTBR-tau243 is a specific biomarker of tau tangle pathology in Alzheimer’s disease.
Nat Med. 2023 Aug;29(8):1954-1963. doi: 10.1038/s41591-023-02443-z.
Read the article